Kljun J

References (4)

Title : Lead Optimization of a Butyrylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease - Kosak_2025_J.Med.Chem__
Author(s) : Kosak U , Strasek Benedik N , Knez D , Zakelj S , Trontelj J , Pislar A , Horvat S , Bolje A , Znidarsic N , Grgurevic N , Svara T , Kljun J , Skrzypczak-Wiercioch A , Lv B , Xiong Y , Wang Q , Bian R , Shao J , Dias J , Nachon F , Brazzolotto X , Stojan J , Sun H , Salat K , Gobec S
Ref : Journal of Medicinal Chemistry , : , 2025
Abstract :
PubMedSearch : Kosak_2025_J.Med.Chem__
PubMedID: 40454648
Gene_locus related to this paper: human-BCHE

Title : Structural Isomerism and Enhanced Lipophilicity of Pyrithione Ligands of Organoruthenium(II) Complexes Increase Inhibition on AChE and BuChE - Kladnik_2020_Int.J.Mol.Sci_21_
Author(s) : Kladnik J , Ristovski S , Kljun J , Defant A , Mancini I , Sepcic K , Turel I
Ref : Int J Mol Sci , 21 : , 2020
Abstract :
PubMedSearch : Kladnik_2020_Int.J.Mol.Sci_21_
PubMedID: 32781544

Title : Structural and functional characterization of an organometallic ruthenium complex as a potential myorelaxant drug - Trobec_2020_Biomed.Pharmacother_127_110161
Author(s) : Trobec T , Zuzek MC , Sepcic K , Kladnik J , Kljun J , Turel I , Benoit E , Frangez R
Ref : Biomed Pharmacother , 127 :110161 , 2020
Abstract :
PubMedSearch : Trobec_2020_Biomed.Pharmacother_127_110161
PubMedID: 32380389

Title : Organoruthenium Prodrugs as a New Class of Cholinesterase and Glutathione-S-Transferase Inhibitors - Ristovski_2018_ChemMedChem_13_2166
Author(s) : Ristovski S , Uzelac M , Kljun J , Lipec T , Ursic M , Zemljic Jokhadar S , Zuzek MC , Trobec T , Frangez R , Sepcic K , Turel I
Ref : ChemMedChem , 13 :2166 , 2018
Abstract :
PubMedSearch : Ristovski_2018_ChemMedChem_13_2166
PubMedID: 30126080